Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 132702, 11 pages
http://dx.doi.org/10.1155/2014/132702
Review Article

Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer

1Department of Obstetrics and Gynecology, Korean Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, Republic of Korea
2Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 463-707, Republic of Korea
3Biomedical Science Project, Brain Korea 21 Program for Leading Universities & Students, Seoul National University, Seoul 110-799, Republic of Korea
4Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea
5Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea
6Major in Biomodulation, World Class University, Seoul National University, Seoul 151-921, Republic of Korea

Received 28 February 2014; Accepted 29 May 2014; Published 24 June 2014

Academic Editor: Daisuke Aoki

Copyright © 2014 Tae Hun Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [23 citations]

The following is the list of published articles that have cited the current article.

  • Dong Hoon Suh, Hee Seung Kim, Boyun Kim, and Yong Sang Song, “Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: A therapeutic implication,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Johannes Routila, Juho-Antti Mäkelä, Heikki Luukkaa, Ilmo Leivo, Heikki Irjala, Jukka Westermarck, Antti Mäkitie, and Sami Ventelä, “Potential role for inhibition of protein phosphatase 2A tumor suppressor in salivary gland malignancies,” Genes, Chromosomes and Cancer, 2015. View at Publisher · View at Google Scholar
  • Atsushi Imai, Satoshi Ichigo, Kazutoshi Matsunami, Hiroshi Takagi, and Keigo Yasuda, “Clinical benefits of metformin in gynecologic oncology (Review),” Oncology Letters, vol. 10, no. 2, pp. 577–582, 2015. View at Publisher · View at Google Scholar
  • Kathleen A. Vermeersch, Lijuan Wang, Roman Mezencev, John F. McDonald, and Mark P. Styczynski, “OVCAR-3 Spheroid-Derived Cells Display Distinct Metabolic Profiles,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Mirjana Pavlovic, Bela Balint, Mirjana Pavlovic, and Bela Balint, “Mitochondrial Respiration of Cancer Stem Cell,” Bioengineering and Cancer Stem Cell Concept, pp. 89–95, 2015. View at Publisher · View at Google Scholar
  • Mirjana Pavlovic, Bela Balint, Mirjana Pavlovic, and Bela Balint, “Metabolism in Cancer Stem Cell,” Bioengineering and Cancer Stem Cell Concept, pp. 97–102, 2015. View at Publisher · View at Google Scholar
  • Xinbing Sui, Yinghua Xu, Xian Wang, Weidong Han, Hongming Pan, and Mang Xiao, “Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment,” Molecular Pharmaceutics, pp. 151002102441003, 2015. View at Publisher · View at Google Scholar
  • Bela Balint, and Mirjana Pavlovicpp. 1–144, 2015. View at Publisher · View at Google Scholar
  • Ramandeep Rattan, Jasdeep Chhina, Rouba Ali-Fehmi, Zaid Al-Wahab, Ismail Mert, Calvin Tebbe, Miriana Hijaz, Robert T. Morris, Shailendra Giri, and Adnan R. Munkarah, “Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: Similarity with calorie restriction,” Oncotarget, vol. 6, no. 13, pp. 10908–10923, 2015. View at Publisher · View at Google Scholar
  • Corti Denise, Elena Sacco, Anna Caselli, Marco Vanoni, Matteo Landriscina, Paolo Cirri, Paola Chiarugi, Paolo Paoli, Maura Calvani, Maria Letizia Taddei, Elisa Giannoni, Scott Kopetz, Syed Mohammad Ali Kazmi, Morelli Maria Pia, and Piergiorgio Pettazzoni, “5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits,” Oncotarget, vol. 6, no. 39, pp. 41706–41721, 2015. View at Publisher · View at Google Scholar
  • HyeRan Gwak, Youngmin Kim, Haein An, Danny N. Dhanasekaran, and Yong Sang Song, “Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer,” Molecular Carcinogenesis, vol. 56, no. 2, pp. 349–358, 2016. View at Publisher · View at Google Scholar
  • Marie Daugan, Benoit d'Hayer, Amélie Dufaÿ Wojcicki, and Vincent Boudy, “Metformin: An anti-diabetic drug to fight cancer,” Pharmacological Research, vol. 113, pp. 675–685, 2016. View at Publisher · View at Google Scholar
  • Maria E. Garcia-Rubino, Cesar Lozano-Lopez, and Joaquin M. Campos, “Inhibitors of cancer stem cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 16, no. 10, pp. 1230–1239, 2016. View at Publisher · View at Google Scholar
  • Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann, and Yi Lin, “Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy,” Current Drug Targets, vol. 17, no. 8, pp. 853–864, 2016. View at Publisher · View at Google Scholar
  • Mirjana Pavlović, Ksenija Radotić, Mirjana Pavlović, and Ksenija Radotić, “Metabolic Reprogramming in Cancer and Metabolic Theory of CSC,” Animal and Plant Stem Cells, pp. 99–112, 2017. View at Publisher · View at Google Scholar
  • Mirjana Pavlovic, and Ksenija Radoticpp. 1–234, 2017. View at Publisher · View at Google Scholar
  • Xiaoyang Zhang, Yarong Liu, Yu Jeong Kim, John Mac, Rachel Zhuang, and Pin Wang, “Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment,” RSC Adv., vol. 7, no. 32, pp. 19685–19693, 2017. View at Publisher · View at Google Scholar
  • Açelya Yilmazer, “Evaluation of cancer stemness in breast cancer and glioblastoma spheroids in vitro,” 3 Biotech, vol. 8, no. 9, 2018. View at Publisher · View at Google Scholar
  • Marwa Al Hassan, Isabelle Fakhoury, Zeinab El Masri, Noura Ghazale, Rayane Dennaoui, Oula El Atat, Amjad Kanaan, and Mirvat El-Sibai, “Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells,” Analytical Cellular Pathology, vol. 2018, pp. 1–9, 2018. View at Publisher · View at Google Scholar
  • Marion M. Chan, Rensa Chen, and Dunne Fong, “Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations,” Cancer Letters, vol. 433, pp. 53–64, 2018. View at Publisher · View at Google Scholar
  • Monica Gatti, Agnese Solari, Alessandra Pattarozzi, Chiara Campanella, Stefano Thellung, Lorella Maniscalco, Raffaella De Maria, Roberto Würth, Alessandro Corsaro, Adriana Bajetto, Alessandra Ratto, Angelo Ferrari, Antonio Daga, Federica Barbieri, and Tullio Florio, “In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity,” Experimental Cell Research, 2018. View at Publisher · View at Google Scholar
  • Hua Zhou, Abdul Mondal, Aleksandra Dakic, Lama Alhawas, Xuefeng Liu, and Zhixu He, “Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells,” BioMed Research International, vol. 2018, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Xingyue Zong, and Kenneth P. Nephew, “Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting,” Cancers, vol. 11, no. 7, pp. 934, 2019. View at Publisher · View at Google Scholar